Table 2. Normal versus Increased LV Wall Thickness.
| Normal Wall Thickness | Increased Wall Thickness | |||
|---|---|---|---|---|
| n = 28 | n = 21 | p< | ||
| Clinical Data | Age (years) | 56±12 | 62±14 | n.s. |
| Female (%) | 11 (39) | 12 (57) | n.s. | |
| BMI (kg/m2) | 28±4 | 30±6 | n.s. | |
| Resting BP (mmHg) | 127/76 | 131/77 | n.s./n.s. | |
| Resting HR (min-1) | 67±8 | 66±9 | n.s. | |
| Test Indication | Dyspnea (%) | 6 (21) | 5 (24) | n.s. |
| Chest pain (%) | 14 (50) | 5 (24) | n.s. | |
| CAD (%) | 5 (18) | 7 (33) | n.s. | |
| Other (%) | 3 (11) | 4 (19) | n.s. | |
| Cardiovascular Risk Factors | Hyperlipidemia (%) | 22 (79) | 14 (67) | n.s. |
| Current smoker (%) | 4 (14) | 1 (5) | n.s. | |
| Diabetes Mellitus (%) | 2 (7) | 2 (10) | n.s. | |
| Hypertension (%) | 11 (39) | 18 (86) | 0.005 | |
| Medications | Beta blocker (%) | 4 (14) | 7 (33) | n.s. |
| ACEI/ARB (%) | 9 (32) | 11 (52) | n.s. | |
| CCB (%) | 7 (25) | 7 (33) | n.s. | |
| ASA (%) | 10 (36) | 12 (57) | n.s. | |
| Statin (%) | 16 (57) | 8 (38) | n.s. | |
| Diuretic (%) | 2 (7) | 6 (29) | n.s. | |
| Baseline Echocardiography | Septal Wall (mm) | 8.5±1.3 | 13.7±1.8 | 0.001 |
| Posterior Wall (mm) | 8.0±1.2 | 11.9±1.8 | 0.001 | |
| Mean Wall Thickness (mm) | 7.5±1.3 | 12.7±1.8 | 0.001 | |
| LVEDD (mm) | 56±7 | 49±9 | 0.005 | |
| LV mass (g) | 174±49 | 251±87 | 0.001 | |
| LV mass index (g/m2.7) | 39±9 | 60±19 | 0.001 | |
| EDV (mL) | 87±29 | 70±23 | 0.05 | |
| ESV (mL) | 30±18 | 25±15 | n.s. | |
| EF (%) | 62±10 | 65±9 | n.s. | |
| LV Size (mL) | 188±54 | 206±62 | n.s. | |